Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Improved interpretation of genotypic changes in the HIV-1 reverse transcriptase coding region that determine the virological response to didanosine.
Viral failure in HIV-infected patients with long-lasting viral suppression who discontinued enfuvirtide.
Constraints on HIV-1 evolution and immunodominance revealed in monozygotic adult twins infected with the same virus.
Treatment of monocytes with interleukin (IL)-12 plus IL-18 stimulates survival, differentiation and the production of CXC chemokine ligands (CXCL)8, CXCL9 and CXCL10.
The effect of atorvastatin treatment on HIV-1-infected patients interrupting antiretroviral therapy.
Genetic evolution of gp41 reveals a highly exclusive relationship between codons 36, 38 and 43 in gp41 under long-term enfuvirtide-containing salvage regimen.
Increased antiretroviral potency by the addition of enfuvirtide to a four-drug regimen in antiretroviral-naive, HIV-infected patients.
HIV-1 subtypes and response to combination antiretroviral therapy in Europe.
Naive CD4(+) T cells and recent thymic emigrant levels in treated individuals with HIV: clinical relevance.
Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients.